Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9108
High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study
Requena-Méndez, Ana | Salas-Coronas, Joaquin | Salvador, Fernando | Gomez-Junyent, Joan | Villar-Garcia, Judith | Santin, Miguel | Muñoz, Carme | González-Cordón, Ana | Cabezas Fernández, Maria Teresa | Sulleiro, Elena | Arenas, Maria Del Mar | Somoza, Dolors | Vazquez-Villegas, Jose | Treviño, Begoña | Rodríguez, Esperanza ISCIII | Valls, Maria Eugenia | LLaberia-Marcual, Jaume | Subirá, Carme | Muñoz, Jose
Pathogens. 2020 Feb 11;9(2). pii: E107.
Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S.stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S.stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S.stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
Files in this item
- HighPrevalenceOfStrongyloidias ...